JOHN KYALO MUTHUKA

Dr. JOHN KYALO MUTHUKA

Kenya Medical Training College, Nairobi, Nairobi City, Kenya
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2022 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
MKMichael Kiptoo
Michael Kiptoo
KOKelly Oluoch
Kelly Oluoch
JNJapheth Mativo Nzioki
Japheth Mativo Nzioki
ENEverlyn Musangi Nyamai
Everlyn Musangi Nyamai
Background: COVID-19 was first identified in Wuhan, China, in December 2019, spreading to the rest of the globe, becoming a pandemic. Some studies have shown an association between pregnancy status and severe COVID-19 with a cytokine storm, whereas others have shown contrasting results. Objective: The aim of this study was to examine the relationship between pregnancy status and the clinical COVID-19 severity characterized by the cytokine storm through a systematic review and meta-analysis. Methods: We searched the Google Scholar, PubMed, Scopus, Web of Science, and Embase databases to identify clinical studies suitable for inclusion in this meta-analysis. Studies reporting pregnancy status and comparing the COVID-19 severity cytokine storm outcome were included. COVID-19 severity characterized by a cytokine storm was described using parameters such as intensive care unit admission, invasive mechanical ventilation, mechanical ventilation, hospital admission, pro- and anti-inflammatory cytokine levels, consolidation on chest computed tomography scan, pulmonary infiltration, extreme fevers as characteristic of a cytokine storm, syndromic severity, higher neutrophil count indicative of a cytokine storm, and severe COVID-19 presentation. Results: A total of 17 articles including data for 840,332 women with COVID-19 were included. This meta-analysis revealed a correlation between positive pregnancy status and severe COVID-19 with a cytokine storm (random-effects model odds ratio [OR] 2.47, 95% CI 1.63-3.73; P<.001), with a cumulative incidence of 6432 (14.1%) and 24,352 (3.1%) among pregnant and nonpregnant women with COVID-19, respectively. The fixed-effects model also showed a correlation between pregnancy status and severe COVID-19 with a cytokine storm (OR 7.41, 95% CI 7.02-7.83; P<.001). Considerable heterogeneity was found among all pooled studies (I²=98%, P<.001). Furthermore, the updated analysis showed substantially low heterogeneity (I²=29 %, P=.19), and the funnel plot revealed no publication bias. The subanalysis between single-center and multicenter studies demonstrated similar heterogeneity (I2=72% and 98%, respectively). Sensitivity analysis on each subgroup revealed that pregnancy was significantly related to severe COVID-19 with a cytokine storm from single-center studies (fixed-effects model OR 3.97, 95% CI 2.26-6.95; P<.001) with very low heterogeneity (I²=2%, P=.42). Conclusions: Being pregnant is clearly associated with experiencing a severe course of COVID-19 characterized by a cytokine storm. The COVID-19 pandemic should serve as an impetus for further research on pregnant women diagnosed with COVID-19 to map out the salient risk factors associated with its severity. Trial Registration: PROSPERO CRD42021242011; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=242011.

5 July 2024 in COVID
Verified
Journal Article
Open access
PDF file
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
JNJapeth Mativo Nzioki
Japeth Mativo Nzioki
JKJack Oluoch Kelly
Jack Oluoch Kelly
EMEverlyn Nyamai Musangi
Everlyn Nyamai Musangi
LCLucy Chepkemei Chebungei
Lucy Chepkemei Chebungei
MKMichael Kibet Kiptoo
Michael Kibet Kiptoo
Objectives: We aimed to assess the prevalence of long COVID-19 and estimate the average time to its diagnosis and meta-regression for covariates. Methods: We conducted a systematic review, meta-analysis, and meta-regression from 43 studies (367,236 patients) (June 2020–August 2022). With the random-effects model, the pooled prevalence of long COVID-19 was measured. Publication bias was ascertained, and meta-regression analysis was performed on predetermined covariates. The trial was registered with PROSPERO (CRD42022328509). Results: The pooled prevalence of long COVID-19 was 42.5% (95% CI 36% to 49.3%), with 25% and 66% at four and two months, respectively. Mostly, long COVID-19 signs and symptoms occurred at three (54.3%) to six (57%) months (p < 0.0001), further increasing at 12 months (57.9%, p = 0.0148). Hypertension was significantly associated with long COVID-19 at 32% (0.322 (95% CI 0.166, 0.532) (p < 0.001) and hospital re-admission contributed to 17% (Q = 8.70, df = 1, p = 0.0032) (R2 = 0.17). All the covariates explained at least some of the variance in effect size on long COVID-19 at 53% (Q = 38.81, df = 19, p = 0.0047) (R2 analog = 0.53). Conclusion: The prevalence of long COVID-19 was 42.5% when linked with a cardiovascular disorder. Hospital re-admission majorly predicted the incidence of long COVID-19. Clinical and methodological characteristics in a specific study contributed to over 50% of long COVID-19 events, with most signs and symptoms occurring between 3 and 6 months and increasing at 12 months.

26 May 2022 in European Journal of Public Health Studies
Verified
Journal Article
Open access
PDF file
KOKelly Oluoch
Kelly Oluoch
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
FWFrancis Wabmura
Francis Wabmura
MMMirrium Muthoka
Mirrium Muthoka
EDEdwin Dede
Edwin Dede
SNSamuel Ndukanio
Samuel Ndukanio
In an effort to mitigate the outbreak of COVID-19, many countries have imposed drastic lockdown, movement control, or shelter-in-place orders on their residents. The effectiveness of these mitigation measures is highly dependent on the cooperation and compliance of all members of society. The knowledge, attitudes, and practices people hold toward the disease play an integral role in determining a society’s readiness to accept behavioral change measures from health authorities. Urban informal settlements are characterized by large populations occupying a small land area. Housing in informal settlements is close to each other with most households making do with poor quality and erratic water supply. How challenges of sanitation in slum dwellings in Kenya affect the spread of COVID-19 is not known. Social distancing, wearing masks and hand washing among other measures are known to reduce the spread of COVID-19. Although access to hand-washing facilities with soap and water is nearly universal in high-income countries, the same is not true for low-income countries. The purpose of this survey was to assess the challenges of hand washing as a COVID-19 prevention measure among urban slum populations in Kenya. Key information of practices on hand-washing practices among this sub-population will inform the ministry of health, its collaborators, and interested health sectors, on areas of improvement. A descriptive cross-sectional survey for quantitative data was used. Solvins formula for the calculation of sample size was used. A properly designed data collection tool was used in collecting the primary data on hand washing to prevent transmission of COVID-19 with a combination of face-to-face interviews. A pre-test of the data collection tool prior to pilot data collection was performed to ascertain validity and reliability. Data was analyzed using descriptive statistics such as frequencies, mean and standard deviation and displayed using tables and figures. Inferential statistics for predictive associations between variables was performed. In the analysis, data was combined to allow reporting on an array of issues. The results indicate salient challenges on hand-washing and show an acceptable level of knowledge in mitigating COVID-19 through hand-washing and hygiene and, highlight the importance of consistent messaging from local health authorities and the government as well as the need for tailored community health education and sensitization programs to improve levels of knowledge, attitudes, and practices mostly on handwashing as this pandemic may be there for some time or there could be a possible upsurge in future. Article visualizations:

6 October 2025 in JMIRx Med
Verified
Journal Article
Open access
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
DMDianna Kageni Mbari-Fondo
Dianna Kageni Mbari-Fondo
FWFrancis Muchiri Wambura
Francis Muchiri Wambura
KOKelly Oluoch
Kelly Oluoch
JNJapheth Mativo Nzioki
Japheth Mativo Nzioki
RNRosemary Nabaweesi
Rosemary Nabaweesi
Background: The COVID-19 pandemic presented many unknowns for pregnant women, with anemia potentially worsening pregnancy outcomes due to multiple factors. Objective: This review aimed to determine the pooled effect of maternal anemia interventions and associated factors during the pandemic. Methods: Eligible studies were observational and included reproductive-age women receiving anemia-related interventions during the COVID-19 pandemic. Exclusion criteria comprised non-English publications, reviews, editorials, case reports, studies with insufficient data, sample sizes below 50, and those lacking DOIs. A systematic search of PubMed, Scopus, Embase, Web of Science, and Google Scholar identified articles published between December 2019 and August 2022. Risk of bias was evaluated using the Cochrane Risk of Bias 2 tool for randomized trials and the National Institutes of Health’s assessment tool for observational studies. Pooled rate ratios (RRs) with 95% CIs were calculated in Review Manager 5.4.1. Synthesis included subgroup analysis, meta-regression, and publication bias checks to assess intervention effectiveness. Results: This meta-analysis included 11 studies with 6129 pregnant women. Of these, 3591 (59%) were in the intervention group and 2538 (41%) were in the comparator group. Effects were recorded for 1921 (53.4%) women in the intervention group and 1350 (53.1%) in the comparator group. The cumulative impact ranged from 23% to 81%, averaging 56%. The initial analysis showed no significant effect on anemia prevention (RR 0.79, 95% CI 0.61‐1.02; P =.07), with high heterogeneity ( I ²=97%). Sensitivity analysis excluding 4 outlier studies improved the effect size to a significant level at 39% (RR 0.61, 95% CI 0.43‐0.87; P =.006). Subgroup analysis revealed substantial heterogeneity ( I ²=87.2%). Intravenous sucrose had a poor impact (RR 1.31, 95% CI 1.17‐1.47; P <.001), while medicinal or herbal interventions showed benefit (RR 0.81, 95% CI 0.73‐0.90; P =.006). Educational interventions yielded a 28% effect (RR 0.72), medicinal administration 19% (RR 0.81), iron supplementation 17% (RR 0.83), and intravenous ferric carboxylmaltose 15% (RR 0.85; P <.02). Additional sensitivity analysis confirmed a pooled positive effect of 17% (RR 0.83, 95% CI 0.79‐0.88; P <.001), with minimal heterogeneity ( I ²=0%). Regionally, effectiveness was highest in Africa (RR 0.84, 95% CI 0.79‐0.89; P <.001). Multicenter studies and those with 2020 data were predictive of better outcomes (RR 0.84 and RR 0.50, respectively). Despite initial heterogeneity and publication bias, interventions showed utility in mitigating maternal anemia in targeted subgroups and regions. Conclusions: Maternal anemia interventions during the COVID-19 pandemic showed modest, context-specific effectiveness, with declining impact from 2020 to 2022. Although high heterogeneity and study inconsistencies limited generalizability, significant benefits were observed particularly in African and multicenter studies. The pandemic exposed gaps in maternal health systems, emphasizing the need for tailored interventions, stronger data infrastructure, and resilient care strategies in future global crises.

6 February 2023 in Cureus
Verified
Journal Article
Open access
PDF file
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
KOKelly Oluoch
Kelly Oluoch
FWFrancis M. Wambura
Francis M. Wambura
JNJapheth M. Nzioki
Japheth M. Nzioki
RNRosemary Nabaweesi
Rosemary Nabaweesi
The aim of this review was to evaluate the risk of COVID-19 cytokine release syndrome (CRS) with HIV infection and meta-regress for indicator covariates. Electronic databases, including Google Scholar, Cochrane Library, Web of Sciences (WOS), EMBASE, Medline/PubMed, COVID-19 Research Database, and Scopus, were systematically searched till February 30, 2022. All human studies were included, irrespective of publication date or region. Eleven studies, with a total of 2,005,274 detailing cytokine release syndrome defined by specific parameters, were included. To pool the estimate, a random-effects model with risk ratio (RR) as the effect measure was used. Moreover, publication bias and sensitivity analysis were evaluated followed by meta-regression analysis to account for any possible covariates. This systematic review, meta-analysis, and meta-regression trial was registered (CRD42021264761) on the PROSPERO register. HIV infection showed an increased risk for COVID-19 cytokine release syndrome (RR= 1.48, 95% CI (1.16, 1.88) (P=0.002)) with substantial heterogeneity (I2 > 80%) and a 4.6% cumulative incidence. The true effects size in 95% of all the comparable populations (prediction interval) fell between 0.67 to 3.29. HIV infection further showed an increased risk for intensive care unit (ICU) admission ((P<0.0001) (I² = 0%)] and mechanical ventilation (MV) ((P=0.04) (I² = 0%)) as the key indicators of cytokine release syndrome. Meta-regression analysis demonstrated that COVID-19 cytokine release syndrome was influenced by the year a study was published (R² = 0.55) and the region from where the study was conducted (R² = 0.11). On meta-regression analysis, the combined impact of all covariates in the model explained at least some of the variance in effect size (Q = 16.21, df = 6, P= 0.0127), and the proportion of variance explained by covariates on comparing the model with and without the covariates was 73 % and highly significant (Tau² = 0.1100, Tau = 0.3317, I² = 86.5%, Q = .99, df = 10, P<0.0001) (R² = 0.73). Our updated meta-analysis indicated that HIV infection was significantly associated with an increased risk for COVID-19 cytokine release syndrome, which, in addition, might be moderated by the year a study was published and the region in which the study was conducted. Further, the risk for intensive care unit (ICU) admission and mechanical ventilation (MV) were identified as the key indicators of cytokine release syndrome. We believe the updated data anchoring cytokine release syndrome will contribute to more substantiation of the findings reported by similar earlier studies.

26 January 2024 in Cureus
Verified
Journal Article
Open access
JOHN KYALO MUTHUKAJOHN KYALO MUTHUKA
JOHN KYALO MUTHUKA
ENEverlyn M Nyamai
Everlyn M Nyamai
KOKelly Oluoch
Kelly Oluoch
CMCharles Maibvise
Charles Maibvise
RNRosemary Nabaweesi
Rosemary Nabaweesi
Background and aims: Following antiretroviral therapy (ART) initiation, HIV-associated immune reconstitution inflammatory syndrome (IRIS), indicated by an array of opportunistic infections, may occur, presenting as either paradoxical, a worsening of a previously treated infection, or unmasking, a flare-up of an underlying, previously undiagnosed infection. The impact of ART as the backbone of HIV treatment and prevention has prolonged the survival of people living with HIV. In pregnancy, benefits have been shown by slowing HIV progression and preventing perinatal transmission; however, there have been risks of adverse reactions with ART, including immune responses to both the fetus and mother. This study sought to estimate the incidence of HIV-IRIS cumulatively and by type either paradoxical or unmasking IRIS, determine the baseline maternal and HIV clinical markers as predictors of, and analyze the log-rank test for survival time to IRIS outcome assessed by relying on an increase in CD4 count and/or a rapid decrease in viral load. Methods: An active records study was conducted between June 2019 and March 2020 among ART-na & iuml;ve pregnant women attending the antenatal care units (ANCu) at the Kenyatta National and Mbagathi Hospitals, Nairobi, Kenya. Participants were aged between 20 and 49 years and had a confirmed HIV-positive test. To ascertain a true case of IRIS, the diagnosis was adjudicated for accuracy and consistency by an independent review committee. Plasma HIV viral load, CD4 counts, and routine laboratory evaluations (hemoglobin, white blood cell count (WBC)) were performed by each hospital's clinical laboratory. The IRIS incidence was assessed using the International Network for Studies Against HIV-Associated IRIS (INSHI) during the first three months after ART initiation. Multivariate Cox regression with IRIS as the outcome, using the SPSS Survival package, examined the relationship between baseline maternal characteristics and HIV clinical markers before ART initiation and IRIS, and finally, decision-tree analysis for predicting IRIS was performed. Results: From a pool of 532 ART-na & iuml;ve pregnant women, 133 (25%) developed IRIS, and 97 (72.9%) were in the unmasking category. The accumulated risk of experiencing IRIS symptoms increased from week two (hazard ratio (HR)=0.0287) to week 12 (HR=3.6158). Participants with a maternal BMI (MBMI) of 25-29.9 kg/m(2) at baseline were at a higher risk of unmasking IRIS (HR=2.478; P=0.010). The WHO-HIV clinical stages 1 and 2 skewed towards paradoxical IRIS (regression coefficients =-0.111 and -0.276 (P 500 cells/mm<^>3 skewed towards unmasking IRIS (regression coefficient=0.192, HR=1.211, P=0.416), while RNA-HIV viral loads >50 copies/ml towards paradoxical IRIS (regression coefficient=-0.199, HR=0.820, P=0.360. On decision tree analysis, 85% (P=0.001) of ART-na & iuml;ve pregnant women with a baseline CD4 count below 500 copies/mm<^>3 presented with unmasking IRIS. Conclusion: For ART-na & iuml;ve pregnant women, unmasking IRIS is the most common type, and an MBMI of 25-29.9 kg/m(2), advanced HIV infection, a CD4 count <500 cells/mm<^>3, and a higher parity at baseline may be clinically useful predictors. The higher proportion of ART-na & iuml;ve pregnant women experiencing unmasking as compared to paradoxical IRIS supports the need for earlier assessment based on potential predictors.